Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 2-amino-5-bromo-3-[(trimethylsilyl)ethynyl]-, methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

875305-09-2

Post Buying Request

875305-09-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

875305-09-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 875305-09-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,3,0 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 875305-09:
(8*8)+(7*7)+(6*5)+(5*3)+(4*0)+(3*5)+(2*0)+(1*9)=182
182 % 10 = 2
So 875305-09-2 is a valid CAS Registry Number.

875305-09-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-amino-5-bromo-3-trimethylsilanylethynyl-benzoic acid methyl ester

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:875305-09-2 SDS

875305-09-2Relevant academic research and scientific papers

CD38 INHIBITORS AND METHODS OF TREATMENT

-

, (2016/06/28)

Compounds of Formula (I) and methods of treating diseases of metabolism by modulating cellular NAD+ levels through the inhibition of the CD38 enzyme, are disclosed. Formula (I).

Indole, indazole and indoline derivatives as CETP inhibitors

-

Page/Page column 22, (2010/02/15)

The present invention relates to compounds of formula (I): wherein —X—Y—, R1 to R11 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 875305-09-2